| Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) (NCT02689453) | National Cancer Institute (NCI) | 2017-01-19 |
| PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas (NCT03013491) | CytomX Therapeutics | 2017-01-19 |
| KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response (NCT02757651) | Institute of Cancer Research, United Kingdom | 2017-01-19 |
| A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease (NCT02968108) | Janssen Research & Development, LLC | 2017-01-18 |
| Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02960646) | M.D. Anderson Cancer Center | 2017-01-18 |
| Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer (NCT02935205) | Mamta Parikh | 2017-01-17 |
| Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma (NCT02939183) | Amgen | 2017-01-17 |
| Autologous BMMNC Combined With HA Therapy for PAOD (NCT03214887) | Academia Sinica, Taiwan | 2017-01-17 |
| A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects (NCT03025022) | Janssen Research & Development, LLC | 2017-01-17 |
| A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma (NCT02866747) | Institut Claudius Regaud | 2017-01-17 |
| Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis (NCT02966951) | Hanan Jafar | 2017-01-17 |
| Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884 (NCT03001297) | MedImmune LLC | 2017-01-17 |
| The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants (NCT03012334) | Eli Lilly and Company | 2017-01-16 |
| A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL (NCT03931993) | Allergy Therapeutics | 2017-01-16 |
| Gene Therapy for Achromatopsia (CNGB3) (NCT03001310) | MeiraGTx UK II Ltd | 2017-01-16 |
| A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491 (NCT03062956) | MyoKardia, Inc. | 2017-01-16 |
| Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers (NCT02991222) | Sun Pharma Advanced Research Company Limited | 2017-01-15 |
| Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial (NCT04721301) | University Hospital Heidelberg | 2017-01-15 |
| Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis. (NCT03255278) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-01-15 |
| A Study of LY3202626 in Healthy Participants (NCT03023826) | Eli Lilly and Company | 2017-01-15 |
| MTH1, A Phase I, Study on Tumors Inhibition, First in Human, First in Class (NCT03036228) | Thomas Helleday Foundation | 2017-01-14 |
| Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer (NCT03109249) | Sun Pharma Advanced Research Company Limited | 2017-01-14 |
| The Influence of IgY Max on Inflammatory Markers and the Gut Microbiome (NCT02972463) | Igy Nutrition, LLC | 2017-01-13 |
| Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer (NCT03029871) | Benjamin Movsas, M.D. | 2017-01-13 |
| Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013) (NCT02972034) | Merck Sharp & Dohme LLC | 2017-01-13 |
| Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors (NCT02827968) | 3D Medicines (Sichuan) Co., Ltd. | 2017-01-13 |
| Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions (NCT03141463) | University Medical Center Groningen | 2017-01-13 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects (NCT02927457) | GlaxoSmithKline | 2017-01-13 |
| A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin (NCT03019549) | AstraZeneca | 2017-01-12 |
| A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS) (NCT02942290) | AbbVie | 2017-01-12 |
| Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects (NCT03357939) | Shanghai Henlius Biotech | 2017-01-12 |
| Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT02950220) | Kami Maddocks | 2017-01-12 |
| Effect of Blueberries on Bone Turnover (NCT02630797) | Purdue University | 2017-01-12 |
| To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers (NCT03004404) | Boehringer Ingelheim | 2017-01-12 |
| Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors (NCT03006887) | Eisai Co., Ltd. | 2017-01-12 |
| Transfusion of Biotinylated Red Blood Cells (NCT02757898) | Emory University | 2017-01-11 |
| Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma (NCT04540107) | Susan Chang | 2017-01-11 |
| Preprandial Ghrelin Effect (NCT02913703) | Jenny Tong, MD, MPH | 2017-01-11 |
| A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants (NCT02927873) | GlaxoSmithKline | 2017-01-11 |
| A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants (NCT02985632) | Bristol-Myers Squibb | 2017-01-11 |
| Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis (NCT02947087) | Medical University of South Carolina | 2017-01-11 |
| A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects (NCT02798978) | GlaxoSmithKline | 2017-01-10 |
| Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder (NCT03514810) | Kufa University | 2017-01-10 |
| GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer (NCT02983604) | Gilead Sciences | 2017-01-10 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants (NCT03002025) | Janssen Pharmaceutical K.K. | 2017-01-10 |
| Novel Positron Emission Tomography (PET) Radiotracer to Image Phosphodiesterase-4B (PDE4B) (NCT03030391) | National Institute of Mental Health (NIMH) | 2017-01-10 |
| A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NCT03009344) | Eisai Co., Ltd. | 2017-01-10 |
| Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects (NCT02999191) | Boehringer Ingelheim | 2017-01-10 |
| Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV Infection (NCT01838915) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2017-01-10 |
| Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer (NCT03123978) | University of California, Davis | 2017-01-09 |
| H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology (NCT03014310) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-01-09 |
| Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers (NCT03016520) | Daewoong Pharmaceutical Co. LTD. | 2017-01-09 |
| Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer (NCT03114631) | The Republican Research and Practical Center for Epidemiology and Microbiology | 2017-01-09 |
| A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers (NCT03072056) | Minerva Neurosciences | 2017-01-09 |
| First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors (NCT02977195) | Centre Leon Berard | 2017-01-09 |
| PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers (NCT02603185) | Hemay Pharmaceutical PTY. LTD. | 2017-01-09 |
| Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer (NCT03028311) | M.D. Anderson Cancer Center | 2017-01-09 |
| Different Doses of Vitamin D and T Regulatory Cells in Preterm Infants (NCT03793309) | Cairo University | 2017-01-09 |
| Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases (NCT02602327) | University of California, San Francisco | 2017-01-09 |
| A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781 (NCT03131141) | Nabriva Therapeutics AG | 2017-01-08 |
| Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD (NCT03006367) | Aevi Genomic Medicine, LLC, a Cerecor company | 2017-01-07 |
| Anti PD-1 Neo-adjuvant Treatment for NSCLC (NCT02938624) | Jair Bar, M.D., Ph.D. | 2017-01-07 |
| Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects (NCT04570670) | Banner Life Sciences LLC | 2017-01-06 |
| Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain (NCT02824276) | Brigham and Women's Hospital | 2017-01-06 |
| Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) (NCT03013439) | Pharmacosmos A/S | 2017-01-06 |
| A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502 (NCT04018378) | Korea University Anam Hospital | 2017-01-06 |
| A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer (NCT02991911) | MedImmune LLC | 2017-01-06 |
| Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT02780804) | National Cancer Institute (NCI) | 2017-01-06 |
| Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA) (NCT02863926) | Michael Murphy | 2017-01-06 |
| A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects (NCT02994394) | Otsuka Pharmaceutical Co., Ltd. | 2017-01-06 |
| First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity (NCT03015207) | Novo Nordisk A/S | 2017-01-06 |
| Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4 (NCT04378608) | Beni-Suef University | 2017-01-05 |
| A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM) (NCT02955550) | Celularity Incorporated | 2017-01-05 |
| A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects (NCT03010475) | Novo Nordisk A/S | 2017-01-05 |
| BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab (NCT03020602) | Seema Nagpal | 2017-01-04 |
| Adrecizumab-LPS Study (NCT03083171) | Adrenomed AG | 2017-01-04 |
| Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers (NCT02968914) | AstraZeneca | 2017-01-04 |
| Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers (NCT03005223) | Daewoong Pharmaceutical Co. LTD. | 2017-01-04 |
| Safety of Wharton Jelly in Erectile Dysfunction (NCT02945449) | Sophia Al-Adwan | 2017-01-04 |
| Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors (NCT02966548) | Bristol-Myers Squibb | 2017-01-04 |
| Cangrelor Neonatal PK/PD and Safety Study (NCT02765633) | Chiesi Farmaceutici S.p.A. | 2017-01-03 |
| Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells (NCT03130374) | The Republican Research and Practical Center for Epidemiology and Microbiology | 2017-01-03 |
| Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 (NCT02775292) | Jonsson Comprehensive Cancer Center | 2017-01-03 |
| Immunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors. (NCT02977156) | Centre Leon Berard | 2017-01-03 |
| A Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Labeled Risdiplam (RO7034067) in Healthy Male Participants (NCT03036501) | Hoffmann-La Roche | 2017-01-03 |
| DP-R213 Phase 1 Pharmacokinetics Study (NCT03010267) | Alvogen Korea | 2017-01-03 |
| Oxytocin HIV Meth Study (NCT02881177) | University of California, San Francisco | 2017-01-01 |
| Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia (NCT02989753) | Valbiotis | 2017-01-01 |
| Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer (NCT02992977) | Agenus Inc. | 2017-01-01 |
| Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital Trauma (NCT03240822) | Wake Forest University Health Sciences | 2017-01-01 |
| Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers (NCT03031535) | Dauntless Pharmaceuticals | 2017-01-01 |
| Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome (NCT03019653) | Mayo Clinic | 2017-01-01 |
| Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2 (NCT02943486) | Universidad Autónoma de Bucaramanga | 2017-01-01 |
| A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL (NCT03018093) | Shanghai AbelZeta Ltd. | 2017-01-01 |
| Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes (NCT05925829) | Hayandra Peduli Foundation | 2017-01-01 |
| G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (NCT02983071) | G1 Therapeutics, Inc. | 2017-01-01 |
| CD36 in Nutrient Delivery and Its Dysfunction (NCT03012386) | Vanderbilt University Medical Center | 2017-01-01 |
| A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1) (NCT03011125) | First Affiliated Hospital of Zhejiang University | 2017-01-01 |
| Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity (NCT03024957) | Assiut University | 2017-01-01 |
| A 3D Printed Assistive Technology Intervention (NCT03353038) | Florida International University | 2017-01-01 |